Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Blood ; 100 (2002), 4. - S. 1354-1361. - ISSN 0006-4971. - eISSN 1528-0020
- Classification
-
Biowissenschaften, Biologie
- Event
-
Veröffentlichung
- (where)
-
Konstanz
- (who)
-
Bibliothek der Universität Konstanz
- (when)
-
2002
- Creator
- URN
-
urn:nbn:de:bsz:352-221379
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 11:03 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Scandella, Elke
- Men, Ying
- Gillessen, Silke
- Forster, Reinhold
- Groettrup, Marcus
- Bibliothek der Universität Konstanz
Time of origin
- 2002
Other Objects (12)
Prostaglandin E2 is a key factor for monocyte-derived dendritic cell maturation : enhanced T cell stimulatory capacity despite IDO
Prostaglandin E2 inhibits IL-23 and IL-12 production by human monocytes through down-regulation of their common p40 subunit
Distinct motifs in the chemokine receptor CCR7 regulate signal transduction, receptor trafficking and chemotaxis
The ubiquitin-like modifier FAT10 : much more than a proteasome-targeting signal
No evidence for immunoproteasomes in chicken lymphoid organs and activated lymphocytes
PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines
Recent insights how combined inhibition of immuno/proteasome subunits enables therapeutic efficacy
Editorial Overview: Molecular immunology : targeting the immune system
Subunit specific inhibitors of proteasomes and their potential for immunomodulation
No essential role for tripeptidyl peptidase II for the processing of LCMV-derived T cell epitopes
Advances in Prostate Cancer Immunotherapies
On the Role of the Immunoproteasome in Protein Homeostasis
Prostaglandin E2 is a key factor for monocyte-derived dendritic cell maturation : enhanced T cell stimulatory capacity despite IDO
Prostaglandin E2 inhibits IL-23 and IL-12 production by human monocytes through down-regulation of their common p40 subunit
Distinct motifs in the chemokine receptor CCR7 regulate signal transduction, receptor trafficking and chemotaxis
The ubiquitin-like modifier FAT10 : much more than a proteasome-targeting signal
No evidence for immunoproteasomes in chicken lymphoid organs and activated lymphocytes
PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines
Recent insights how combined inhibition of immuno/proteasome subunits enables therapeutic efficacy
Editorial Overview: Molecular immunology : targeting the immune system
Subunit specific inhibitors of proteasomes and their potential for immunomodulation
No essential role for tripeptidyl peptidase II for the processing of LCMV-derived T cell epitopes
Advances in Prostate Cancer Immunotherapies
On the Role of the Immunoproteasome in Protein Homeostasis
Prostaglandin E2 is a key factor for monocyte-derived dendritic cell maturation : enhanced T cell stimulatory capacity despite IDO
Prostaglandin E2 inhibits IL-23 and IL-12 production by human monocytes through down-regulation of their common p40 subunit
Distinct motifs in the chemokine receptor CCR7 regulate signal transduction, receptor trafficking and chemotaxis
The ubiquitin-like modifier FAT10 : much more than a proteasome-targeting signal
No evidence for immunoproteasomes in chicken lymphoid organs and activated lymphocytes
PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines
Recent insights how combined inhibition of immuno/proteasome subunits enables therapeutic efficacy
Editorial Overview: Molecular immunology : targeting the immune system
Subunit specific inhibitors of proteasomes and their potential for immunomodulation
No essential role for tripeptidyl peptidase II for the processing of LCMV-derived T cell epitopes
Advances in Prostate Cancer Immunotherapies